Hyperglycaemia, a well-known risk factor for ICU-acquired weakness (ICUAW) [6], and its treatment with insulin may disrupt neuronal and muscle cell homeostasis by affecting mitochondrial function and autophagy [30]. This evidence concerns the gene INS and Hyperglycemia.